Searched for
MARC KIKUCHI
Glenmark launches Epinephrine injection in USGlenmark Pharmaceuticals has launched a generic version of Epinephrine injection multiple-dose vial in the US, gaining 180 days of CGT excl...27 Feb, 2025, 10.23 AM IST- Glenmark launches generic ophthalmic solution in US marketGlenmark Pharmaceuticals' subsidiary has introduced Latanoprost ophthalmic solution, a generic medication for glaucoma, in the US market. T...14 Feb, 2025, 10.07 AM IST
- Glenmark launches generic anticoagulant injectable emulsionGlenmark Pharmaceuticals has launched Phytonadione injectable emulsion through its US arm, targeting anticoagulant markets. The 10 mg/mL si...21 Jan, 2025, 10.47 AM IST
- Dr Reddy's acquires MenoLabs' women health brands in USDr. Reddy’s acquired the entire MenoLabs supplements portfolio which includes seven branded products to treat perimenopause and menopause. ...03 Jan, 2024, 04.57 PM IST
- Dr Reddy's to acquire Mayne Pharma US generic portfolio for $105 millionUnder the terms of the agreement, Dr. Reddy’s will acquire the portfolio for an upfront payment of $90 million in cash, contingent payments...27 Feb, 2023, 12.48 PM IST
- Dr Reddy's launches generic Revlimid in US market"We are pleased with the first-to-market launch of two of our six strengths of Lenalidomide Capsules with 180-day market exclusivity. Bring...08 Sep, 2022, 01.04 PM IST
- DRL acquires injectable portfolio from US-based Eton Pharma for $50 millionThe portfolio includes the Biorphen (phenylephrine hydrocholoride) injection and Rezipres (ephedrine hydrochloride) injection NDAs (new dru...24 Jun, 2022, 10.27 PM IST
- Dr Reddy's launches authorised generic of Vasostrict injection“We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19,” says Ma...09 Feb, 2022, 07.21 PM IST
- Dr Reddy's gets FDA nod for generic Revlimid; enjoys 180 days exclusivity"We are pleased with the Agency's approval of Lenalidomide Capsules, 2.5 mg and 20 mg and being eligible for 180-day market exclusivity. We...19 Oct, 2021, 12.22 PM IST
- Dr Reddy's launches generic Invanz injection in US marketWe're excited to extend our strategic partnership with Gland Pharma whose hard work, in collaboration with the team at Dr Reddys, has enabl...12 May, 2021, 11.03 AM IST
- Dr Reddy's launches generic epilepsy drug in US market"We are pleased that this product has been designated as a Competitive Generic Therapy (CGT) by the FDA," Dr Reddy's Laboratories North Ame...02 Feb, 2021, 03.02 PM IST
- Dr Reddy's Laboratories launches over-the-counter eye allergy drop in USDr Reddy's said Olopatadine Hydrochloride Ophthalmic Solution USP, 0.2 per cent and 0.1 per cent, are indicated for the temporary relief of...17 Sep, 2020, 12.29 PM IST
- Dr Reddy's launches generic arthritis drug in US market"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...09 Sep, 2020, 12.30 PM IST
- Dr Reddy's Labs launches generic injection indicated for abortion in USThe company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said i...06 Dec, 2019, 01.47 PM IST
- Dr Reddy's re-launches generic version of Suboxone in US marketIndivior is in a legal battle against the launch of the copycat version of its opioid addiction treatment by competitors.21 Feb, 2019, 01.20 PM IST
Load More
